rs766512544
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_Strong
The NM_001039213.4(CEACAM16):c.1267+1G>A variant causes a splice donor change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000122 in 1,561,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001039213.4 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM16 | NM_001039213.4 | c.1267+1G>A | splice_donor_variant | ENST00000587331.7 | NP_001034302.2 | |||
CEACAM16 | XM_017026795.2 | c.1268G>A | p.Arg423His | missense_variant | 5/5 | XP_016882284.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM16 | ENST00000587331.7 | c.1267+1G>A | splice_donor_variant | 1 | NM_001039213.4 | ENSP00000466561 | P1 | |||
CEACAM16-AS1 | ENST00000662585.1 | n.382-9011C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000100 AC: 2AN: 199328Hom.: 0 AF XY: 0.0000186 AC XY: 2AN XY: 107802
GnomAD4 exome AF: 0.00000994 AC: 14AN: 1409074Hom.: 0 Cov.: 34 AF XY: 0.00000578 AC XY: 4AN XY: 692540
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 31, 2015 | The c.1267+1G>A variant in CEACAM16 has not been previously reported in individu als with hearing loss, but has been identified in 1/26950 of European chromosome s by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbS NP rs766512544). This variant occurs in the invariant region (+1/2) of the 5'spl ice site consensus sequence and is predicted to cause altered splicing leading t o an abnormal or absent protein. A mouse model study shows that homozygous knock out of the CEACAM16 leads to progressive hearing loss, which suggests that loss of function is causative for hearing loss (Kramer 2012). However, the mouse mode l study did not report hearing loss in heterozygous knockout mice, and only miss ense variants have been reported in families with autosomal dominant hearing los s (Zheng 2011, Wang 2015). Therefore, the spectrum of pathogenic variants in the CEACAM16 gene in autosomal dominant hearing loss is not fully known and it is n ot clear whether heterozygous loss-of-function variants are causative for domina nt hearing loss. However, the identification of this variant in a parent with no rmal hearing indicates that the variant is less likely to be causative for domin ant hearing loss. In summary, the clinical significance of the c.1267+1G>A varia nt is uncertain. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 228514). This variant has not been reported in the literature in individuals affected with CEACAM16-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change affects a donor splice site in intron 6 of the CEACAM16 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at